According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings (TTM) are โฌ4.13 B. In 2023 the company made an earning of โฌ3.78 B a decrease over its 2022 earnings that were of โฌ4.38 B.The earnings displayed on this page is the company's Pretax Income.